​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​The Prescription Drug Affordability Board is an independent unit of state government tasked with protecting Marylanders and the Maryland health care system from the high costs of prescription drug products.

​​

Section1

​Announcements

​​
  • UPCOMING MEETING: ​Prescription Drug Affordability Board Stakeholder Council Meeting​, Monday, June 22, 2026 at 2:00PM. Meeting information can be found h​e​​​r​e.

  • WRITTEN COMMENT REQUEST: Draft Proposed Regulations for Comment: The PDAB is soliciting comments on proposed revisions to COMAR 14.01.04 Cost Review Study Process.​​​ 
    • Information can be found he​re.​
  • ​Data Request:  The Maryland Prescription Drug Affordability Board may require covered entities and 340B manufacturers to report information as necessary to complete a study on the implementation, impact, and finances of the 340B program in Maryland, as outlined in 2024 Md. Laws, Chap.​ 962 (HB 1056).  ​Please see the Data request w​ebpage for more information. ​


Join the PDAB Mailing List here​.​


Section2

Get Inv​olved​​​

​​​​

Section3

Section5